BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38570586)

  • 21. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
    Jing CX; Feng Y; Cao X; Xu CG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival.
    Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B
    Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
    Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
    Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX11 expression in mantle cell lymphoma.
    Xu W; Li JY
    Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
    Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
    J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?
    Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
    Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Pathogenesis of Mantle Cell Lymphoma.
    Navarro A; Beà S; Jares P; Campo E
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
    Morsy MHA; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
    Blood; 2024 Jan; 143(19):1953-1964. PubMed ID: 38774451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma.
    Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I
    Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX11 inhibits tumor proliferation and promotes cell adhesion mediated-drug resistance via a CD43 dependent manner in mantle cell lymphoma.
    Yang R; Huo Z; Duan Y; Tong W; Zheng Y; Su Y; Lou L; Zhang Q; Xu S; Peng C; Kuang D; Wang G
    Leuk Lymphoma; 2020 Sep; 61(9):2068-2081. PubMed ID: 32449421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
    He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
    Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
    Abdelrazak Morsy MH; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
    Blood; 2024 May; 143(19):1953-1964. PubMed ID: 38237141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
    Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
    Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.
    Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Vegliante MC; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Calasanz MJ; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Giné E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Beà S; Campo E
    Cancer Res; 2012 Oct; 72(20):5307-16. PubMed ID: 22915760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
    Kuci V; Nordström L; Conrotto P; Ek S
    Leuk Lymphoma; 2016 Aug; 57(8):1883-92. PubMed ID: 26757780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma.
    Petrakis G; Veloza L; Clot G; Gine E; Gonzalez-Farre B; Navarro A; Bea S; Martínez A; Lopez-Guillermo A; Amador V; Ribera-Cortada I; Campo E
    Histopathology; 2019 Nov; 75(5):704-714. PubMed ID: 31173643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.